All Type of News
New drug-pricing reform baffles local drugmakers
Many local drug manufacturers are opposing the government’s plan to compensate the price difference when medical institutions and pharmacies are found to have bought drugs at lower prices than their government-set max...
Yuhan, Boehringer Ingelheim Korea to co-market Twynsta in Korea
Yuhan Corp. and Boehringer Ingelheim Korea announced on October 5 that the two companies have signed an agreement to co-market Twynsta (telmisartan/amlodipine) in Korea.
The domestic hypertension market is estimat...
KFDA approves Zydena 50 mg for once-daily use
The Korea Food and Drug Administration (KFDA) on October 5 approved the domestic sale of Dong-A’s Zydena (udenafil) 50 mg tablets for the treatment of erectile dysfunction, following already available strengths of 100...
Local pharmaceutical industry will revert to 1994
The scrapping of the controversial unified distribution system may revert the country’s drug industry to the level of 1944, according to a lawmaker.
During the recent parliamentary audit to the Ministry of Health a...
Drug price-tapering system should be overhauled
Korea has implemented the drug price-tapering system over the use of medicines, but the measures are far from being effective, according to a lawmaker.
Rep. Won Hee-mok said that the current system should be furthe...
License procedures for health and medical business simplified
Korea will adopt a series of new measures to simplify the establishment procedures of health- and medical business categories, according to Anti-corruption and Civil Rights Commission (ACRC).
A medical device vendo...
Health ministry skeptical over OTC sales in supermarkets
It is too early to allow over-the-counter (OTC) drugs to be sold at supermarkets and other non-pharmaceutical stores, said Health and welfare minister Chin Soo-hee on October 4.
During the annual parliamentary ins...
Health ministry pressed to reconsider new drug-pricing plan
A lawmaker argue that the Ministry of Welfare is required to push up with the economic effectiveness plan to readjust prices and exclude items that are the least cost-effective.
Rep. Park Eun-soo from the oppositio...
Pharmaceutical firms in a mess
The government is implementing a plan to bring down spending on medicines, which made up over 29 percent of the country’s total medical expense in 2009. It by far exceeds the OECD average of 14.5 percent.
The Minis...
Discontent mounting over preferential treatment for hospitals
With a new drug-pricing plan taking effect in October 1, the local pharmaceutical and wholesaling camps have voiced their mounting discontent over the government’s unilateral treatment in favor of medical institutions...
